Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)
NCT ID: NCT01140048
Last Updated: 2022-02-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
343 participants
OBSERVATIONAL
2007-10-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Montelukast in Acute RSV Bronchiolitis
NCT00524693
Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)
NCT00394160
PK Study in 3- to 6- Month-Old Children (0476-268)(COMPLETED)
NCT00394069
A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)
NCT00700661
Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)
NCT00943397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All Enrolled Participants
All participants who completed Protocol 272 and were enrolled in Protocol 374
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* had RSV-induced bronchiolitis at entry into Protocol 272
Exclusion Criteria
18 Months
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Organon and Co
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
Merck Sharp & Dohme LLC
References
Explore related publications, articles, or registry entries linked to this study.
Lu S, Hartert TV, Everard ML, Giezek H, Nelsen L, Mehta A, Patel H, Knorr B, Reiss TF. Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood. Pediatr Pulmonol. 2016 Dec;51(12):1382-1392. doi: 10.1002/ppul.23461. Epub 2016 May 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010_026
Identifier Type: OTHER
Identifier Source: secondary_id
MK-0476-374
Identifier Type: OTHER
Identifier Source: secondary_id
0476-374
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.